ATE404209T1 - Wundheilende pharmazeutische zusammensetzung enthaltend sucralfat, glycin, aluminium acetat und vitamine - Google Patents

Wundheilende pharmazeutische zusammensetzung enthaltend sucralfat, glycin, aluminium acetat und vitamine

Info

Publication number: ATE404209T1
Authority: AT; Austria
Prior art keywords: vitamins; pharmaceutical composition; glycine; composition containing; wound healing
Prior art date: 2005-09-16

Application number

AT05425649T

Other languages

English (en)

Inventor

Domenico Russo

Original Assignee

Italfar Societa A Responsabili

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-09-16

Filing date

2005-09-16

Publication date

2008-08-15

2005-09-16 Application filed by Italfar Societa A Responsabili filed Critical Italfar Societa A Responsabili

2008-08-15 Application granted granted Critical

2008-08-15 Publication of ATE404209T1 publication Critical patent/ATE404209T1/de

Links

239000008194 pharmaceutical composition Substances 0.000 title abstract 2
MNQYNQBOVCBZIQ-JQOFMKNESA-A sucralfate Chemical compound O[Al](O)OS(=O)(=O)O[C@@H]1[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](COS(=O)(=O)O[Al](O)O)O[C@H]1O[C@@]1(COS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)O1 MNQYNQBOVCBZIQ-JQOFMKNESA-A 0.000 title abstract 2
229960004291 sucralfate Drugs 0.000 title abstract 2
239000011782 vitamin Substances 0.000 title abstract 2
229940088594 vitamin Drugs 0.000 title abstract 2
229930003231 vitamin Natural products 0.000 title abstract 2
235000013343 vitamin Nutrition 0.000 title abstract 2
230000029663 wound healing Effects 0.000 title abstract 2
DHMQDGOQFOQNFH-CNRUNOGKSA-N 2-amino-2-tritioacetic acid Chemical compound [3H]C(N)C(O)=O DHMQDGOQFOQNFH-CNRUNOGKSA-N 0.000 title 1
HDYRYUINDGQKMC-UHFFFAOYSA-M acetyloxyaluminum;dihydrate Chemical compound O.O.CC(=O)O[Al] HDYRYUINDGQKMC-UHFFFAOYSA-M 0.000 title 1
229940009827 aluminum acetate Drugs 0.000 title 1
ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 abstract 2
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 2
239000000203 mixture Substances 0.000 abstract 2
LEZWWPYKPKIXLL-UHFFFAOYSA-N 1-{2-(4-chlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl}imidazole Chemical compound C1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 LEZWWPYKPKIXLL-UHFFFAOYSA-N 0.000 abstract 1
VHVPQPYKVGDNFY-DFMJLFEVSA-N 2-[(2r)-butan-2-yl]-4-[4-[4-[4-[[(2r,4s)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one Chemical compound O=C1N([C@H](C)CC)N=CN1C1=CC=C(N2CCN(CC2)C=2C=CC(OC[C@@H]3O[C@](CN4N=CN=C4)(OC3)C=3C(=CC(Cl)=CC=3)Cl)=CC=2)C=C1 VHVPQPYKVGDNFY-DFMJLFEVSA-N 0.000 abstract 1
CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 abstract 1
229930182566 Gentamicin Natural products 0.000 abstract 1
239000004471 Glycine Substances 0.000 abstract 1
BYBLEWFAAKGYCD-UHFFFAOYSA-N Miconazole Chemical compound ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 BYBLEWFAAKGYCD-UHFFFAOYSA-N 0.000 abstract 1
229930193140 Neomycin Natural products 0.000 abstract 1
BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 abstract 1
206010072170 Skin wound Diseases 0.000 abstract 1
239000003242 anti bacterial agent Substances 0.000 abstract 1
229940121375 antifungal agent Drugs 0.000 abstract 1
239000003429 antifungal agent Substances 0.000 abstract 1
WCOATMADISNSBV-UHFFFAOYSA-K diacetyloxyalumanyl acetate Chemical compound [Al+3].CC([O-])=O.CC([O-])=O.CC([O-])=O WCOATMADISNSBV-UHFFFAOYSA-K 0.000 abstract 1
239000006196 drop Substances 0.000 abstract 1
229960003913 econazole Drugs 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
239000000839 emulsion Substances 0.000 abstract 1
229960003276 erythromycin Drugs 0.000 abstract 1
239000000499 gel Substances 0.000 abstract 1
229960004130 itraconazole Drugs 0.000 abstract 1
229960002509 miconazole Drugs 0.000 abstract 1
229960004927 neomycin Drugs 0.000 abstract 1
239000002674 ointment Substances 0.000 abstract 1
239000000843 powder Substances 0.000 abstract 1
229960003600 silver sulfadiazine Drugs 0.000 abstract 1
UEJSSZHHYBHCEL-UHFFFAOYSA-N silver(1+) sulfadiazinate Chemical compound [Ag+].C1=CC(N)=CC=C1S(=O)(=O)[N-]C1=NC=CC=N1 UEJSSZHHYBHCEL-UHFFFAOYSA-N 0.000 abstract 1
239000007921 spray Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT05425649T 2005-09-16 2005-09-16 Wundheilende pharmazeutische zusammensetzung enthaltend sucralfat, glycin, aluminium acetat und vitamine ATE404209T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP05425649A EP1764104B1 (de)	2005-09-16	2005-09-16	Wundheilende pharmazeutische Zusammensetzung enthaltend Sucralfat, Glycin, Aluminium Acetat und Vitamine

Publications (1)

Publication Number	Publication Date
ATE404209T1 true ATE404209T1 (de)	2008-08-15

Family

ID=35690070

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT05425649T ATE404209T1 (de)	2005-09-16	2005-09-16	Wundheilende pharmazeutische zusammensetzung enthaltend sucralfat, glycin, aluminium acetat und vitamine

Country Status (4)

Country	Link
EP (1)	EP1764104B1 (de)
AT (1)	ATE404209T1 (de)
DE (1)	DE602005008964D1 (de)
ES (1)	ES2313267T3 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2956322A1 (fr)	2010-02-17	2011-08-19	Urgo Lab	Utilisation d'oligosaccharides polysulfates synthetiques comme agents de detersion d'une plaie.
WO2017132671A1 (en) *	2016-01-29	2017-08-03	Genadyne Biotechnologies, Inc.	System and method for treating a wound
RU2693228C2 (ru) *	2017-02-08	2019-07-02	Общество с ограниченной ответственностью "ЛЕРАН" (ООО "ЛЕРАН")	Композит для ускоренного заживления ран различной этиологии, применение композита в качестве косметического средства и в качестве лечебного средства в ветеринарии, средство для регенерации кожных покровов на основе композита

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4373519A (en) *	1981-06-26	1983-02-15	Minnesota Mining And Manufacturing Company	Composite wound dressing
US4945084A (en) *	1987-07-08	1990-07-31	Norman Oksman	Method and composition for topically treating anorectal or other dermal wounds
DK530787D0 (da) *	1987-10-09	1987-10-09	Bukh Meditec	Indretning til indfoering i en legemshulhed
DK505488D0 (da) *	1987-12-21	1988-09-09	Bar Shalom Daniel	Middel og anvendelse af samme
FR2646604B1 (fr) *	1989-05-03	1994-02-04	Fabre Medicament Pierre	Composition pour usage externe a base de sucralfate et son procede de preparation
EP0559804B1 (de) *	1990-11-27	2000-03-15	Biolab Pharmaceuticals, Inc.	Behandlung von windelausschlag
WO2002062353A1 (en) *	2001-02-05	2002-08-15	Marie Madeline Wharton	Composition containing sucrafate and a topical anesthetic for human and animals and method of use thereof
DK1383512T3 (da) *	2001-05-03	2004-11-15	Farmigea Spa	Anvendelse af sucralfat til behandling af cervikal erosion
GB0301577D0 (en) *	2003-01-23	2003-02-26	Edko Pazarlama Tanitim Ltd Sti	Topical pharmaceutical and/or cosmetic dispense systems

2005
- 2005-09-16 EP EP05425649A patent/EP1764104B1/de not_active Expired - Lifetime
- 2005-09-16 ES ES05425649T patent/ES2313267T3/es not_active Expired - Lifetime
- 2005-09-16 DE DE602005008964T patent/DE602005008964D1/de not_active Expired - Lifetime
- 2005-09-16 AT AT05425649T patent/ATE404209T1/de not_active IP Right Cessation

Also Published As

Publication number	Publication date
ES2313267T3 (es)	2009-03-01
DE602005008964D1 (de)	2008-09-25
EP1764104A1 (de)	2007-03-21
EP1764104B1 (de)	2008-08-13

Similar Documents

Publication	Publication Date	Title
NL300985I1 (en)	2019-05-08	mogamulizumab
DE60127613D1 (de)	2007-05-16	Metallverbindungen enthaltende antimikrobielle Wundauflagen
FR15C0069I2 (fr)	2016-04-22	Formulation a usage topique d'ivermectine pour le traitement de conditions dermatologiques
MX272772B (es)	2009-12-11	Composiciones formadoras de pelicula para proteger la piel de fluidos corporales y articulos elaborados a partir de las mismas.
ES2657216T3 (es)	2018-03-02	Apósito para la piel o para heridas para la cicatrización húmeda
MX9502035A (es)	1997-02-28	Utilizacion de los compuestos antifungicos y de los compuestos antibacterianos halogenados para la obtencion de composiciones cosmeticas para disminuir o evitar la caida del cabello.
IL154888A (en)	2013-12-31	Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid
HUP0102337A3 (en)	2002-12-28	Process for preparation of compositions for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the upper respiratory tract and/or the ear
WO2003032928A3 (en)	2003-09-18	Therapeutic composition and use
DE3856018D1 (de)	1997-10-09	Verwendung von einer Disaccharidpolysulfat-Aluminium Verbindung zur Herstellung eines Medikaments zur Behandlung von HÄMORRHOIDEN und zur Wundheilung
US4943293A (en)	1990-07-24	Surgical pin site shield
EP1404412A4 (de)	2006-03-01	Behandlung und zusammensetzung für die wundheilung
RU2007101538A (ru)	2008-07-27	Применение фармацевтической композиции, содержащей кальцитриол и пропионат клобетазола, для лечения псориаза
DE602005008964D1 (de)	2008-09-25	Wundheilende pharmazeutische Zusammensetzung enthaltend Sucralfat, Glycin, Aluminium Acetat und Vitamine
JP2004532892A5 (de)	2006-01-05
WO2003005980A3 (de)	2003-09-18	Carnitin enthaltende kosmetische und dermatologische zubereitungen
AU2003220773A1 (en)	2004-09-09	Pharmaceuticals comprising shikonins as active constituent
FR2846236B1 (fr)	2006-07-28	Utilisation d'un oxysterol ou derive, pour le traitement des peaux seches ou du cuir chevelu sec
WO2008000466A3 (de)	2008-05-22	Verwendung einer antimikrobiellen härtenden alginatmasse zur topischen behandlung von wunden und entzündungen in der human-, zahn- und veterinärmedizin sowie für kosmetische zwecke
WO2003051378A3 (en)	2003-10-30	Pharmaceutical composition for topical treatment of skin disorders and skin wounds
MXPA02006448A (es)	2003-09-22	Preparacion externa para tratar dermatitis alergica.
NO20022113L (no)	2002-05-02	Bruk av nitrogenoksid for behandling av sammensnöringer i luftveiene
WO2003007892A3 (de)	2003-12-11	Elektrolythaltige kosmetische und dermatologische zubereitungen zur behandlung und aktiven prävention trockener haut und anderer negativer veränderungen der physiologischen homöostase der haut
KR200311134Y1 (ko)	2003-04-23	은(銀)부착 반창고
Tieman	2002	The price of privacy. Historic patient privacy regulations win immediate praise from hospital lobby, but political ripples show debate is far from over

Legal Events

Date	Code	Title	Description
2009-02-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties